source
- Regenxbio reports positive Duchenne gene therapy trial results, targets FDA approval by 2027Regenxbio announced that its gene therapy for Duchenne muscular dystrophy achieved the required endpoints in a pivotal clinical trial. The data met the study's predefined criteria, which the compa…
- Dr. Jones reports GLP-1 agonists may outperform aspirin in colorectal cancer prevention and tolerabilityDr. Colton Jones presented findings from a retrospective analysis that compared GLP-1 receptor agonists with aspirin for primary prevention of colorectal cancer. The analysis indicated that patien…